Characteristic pattern of reactivation of hepatitis B virus during chemotherapy for solid cancers

Digestive Diseases

Volumn 30, Issue 6, 2012, Pages 541-546

  Hagiwara, Satoru ^a   Sakurai, Toshiharu ^a   Nishina, Shinichi ^a   Tanaka, Kaoru ^a   Ikeda, Masafumi ^b   Ueshima, Kazuomi ^a   Minami, Yasunori ^a   Inoue, Tatsuo ^a   Yada, Norihisa ^a   Kitai, Satoshi ^a   Takita, Masahiro ^a   Nagai, Tomoyuki ^a   Hayaishi, Sousuke ^a   Arizumi, Tadaaki ^a   Park, Ah Mee ^a   Munakata, Hiroshi ^a   Nishida, Naoshi ^a   Kudo, Masatoshi ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b National Cancer Center   (Japan)

Author keywords

Chemotherapy; Hepatitis B virus reactivation; Solid cancer

Indexed keywords

ALANINE AMINOTRANSFERASE; CISPLATIN; DOCETAXEL; FLUOROURACIL; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADULT; AGED; ANTIBODY BLOOD LEVEL; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONFERENCE PAPER; DISEASE COURSE; FEMALE; HEPATITIS B VIRUS; HUMAN; LIMIT OF QUANTITATION; LUNG CANCER; MALE; NONHUMAN; PRIORITY JOURNAL; TREATMENT DURATION; VIRUS REACTIVATION;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; VIRAL LOAD; VIRUS ACTIVATION;

EID: 84871848438     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000343056     Document Type: Conference Paper

References (17)

1. Hui CK, Cheung WW, Zhang HY, Au WY, Yueng YH, Leung AY, Leung N, Luk JM, Lie AK, Kwong YL, Liang R, Lau GK: Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy. Gastroenterology 2006; 131: 59-68. (Pubitemid 44015749)
2. Calabrese LH, Zein NN, Vassilopoulos D: Hepatitis B virus reactivation with immunosuppressive therapy in rheumatic diseases: Assessment and preventive strategies. Ann Rheum Dis 2006; 65: 983-989. (Pubitemid 44133258)
3. Esteve M, Saro C, González-Huix F, Suarez F, Forné M, Viver JM: Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: Need for primary prophylaxis. Gut 2004; 53: 1363-1365. (Pubitemid 39120128)
4. Wursthorn K, Wedemeyer H, Manns MP: Managing HBV in patients with impaired immunity. Gut 2010; 59: 1430-1445.
5. Kusumoto S, Tanaka Y, Mizokami M, Ueda R: Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma. Int J Hematol 2009; 90: 13-23.
6. Lok AS, Liang RH, Chiu EK, Wong KL, Chan TK, Todd D: Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 1991; 100: 182-188.
7. Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, Hasnian SS, Leung N, Lesmana L, Phiet PH, Sjalfoellah Noer HM, Sollano J, Sun HS, Xu DZ: Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 2000; 15: 1356-1361. (Pubitemid 32052906)
8. Mason AL, Xu L, Guo L, Kuhns M, Perrillo RP: Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen. Hepatology 1998; 27: 1736-1742. (Pubitemid 28264703)
9. Yeo W, Chan TC, Leung NW, Lam WY, Mo FK, Chu MT, Chan HL, Hui EP, Lei KI, Mok TS, Chan PK: Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab. J Clin Oncol 2009; 27: 605-611.
10. Uemoto S, Sugiyama K, Marusawa H, Inomata Y, Asonuma K, Egawa H, Kiuchi T, Miyake Y, Tanaka K, Chiba T: Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants. Transplantation 1998; 65: 494-499. (Pubitemid 28136490)
11. Dervite I, Hober D, Morel P: Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab. N Engl J Med 2001; 344: 68-69. (Pubitemid 32064857)
12. Yoshida T, Kusumoto S, Inagaki A, Mori F, Ito A, Ri M, Ishida T, Komatsu H, Iida S, Sugauchi F, Tanaka Y, Mizokami M, Ueda R: Reactivation of hepatitis B virus in HBsAgnegative patients with multiple myeloma: Two case reports. Int J Hematol 2010; 91: 844-849.
13. Lau GK: Hepatitis B reactivation after chemotherapy: Two decades of clinical research. Hepatol Int 2008; 2: 152-162. (Pubitemid 351650143)
14. Hoofnagle JH: Reactivation of hepatitis B. Hepatology 2009; 49:S156-S165.
15. Hsu C, Hsiung CA, Su IJ, Hwang WS, Wang MC, Lin SF, Lin TH, Hsiao HH, Young JH, Chang MC, Liao YM, Li CC, Wu HB, Tien HF, Chao TY, Liu TW, Cheng AL, Chen PJ: A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial. Hepatology 2008; 47: 844-853. (Pubitemid 351449676)
16. Yeo W, Johnson PJ: Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy. Hepatology 2006; 43: 209-220.
17. Lalazar G, Rund D, Shouval D: Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies. Br J Haematol 2007; 136: 699-712.